Here We Go Again: DFARS Changes to the "Only One Offer" Rule
Client Alert | 1 min read | 07.30.19
As we noted in a recent post, for several years, the Defense Federal Acquisition Regulation Supplement (DFARS) has contained a rule at DFARS 215.371-3(a) that if only one offer is received, even if submitted with the expectation of competition, the adequate price competition exception from the requirement to submit certified cost or pricing data does not apply unless an official at a level above the Contracting Officer (CO) approves the determination that the price is reasonable. On June 28, 2019, DoD issued a final rule to implement Section 822 of the Fiscal Year 2017 National Defense Authorization Act, which eliminates DFARS 215.371-3(a) and, thus, the applicability of the adequate price competition exception under FAR 15.403-1(b)(1) to single-offer situations. The rule also, among other things:
- Streamlines the existing requirements at DFARS 215.371-3(b), with additional emphasis on the requirement to obtain certified cost or pricing data when only one offer is received; and
- Imposes responsibility on offerors for determining whether a subcontractor qualifies for an exception from the certified cost or pricing data requirement on the basis of adequate competition.
On July 16, 2019, DoD issued minor technical corrections to the rule, which is effective July 31, 2019.
Contacts
Insights
Client Alert | 5 min read | 02.23.26
UK Government Seeks Evidence on Ownership and Control in Financial Sanctions Regulations
The UK’s Office of Financial Sanctions Implementation (OFSI) has launched a call for evidence concerning the "ownership and control" test within UK financial sanctions. The call for evidence, running until 11:59 p.m. on 13 April 2026, seeks stakeholder views on the challenges and implementation of the "control" limb, with particular focus on its hypothetical element.
Client Alert | 4 min read | 02.20.26
Client Alert | 7 min read | 02.20.26
Section 5949 Proposed Rule Puts the FAR Council's Chips on the Table
Client Alert | 5 min read | 02.20.26
Trump Administration Pursues MFN Pricing for Prescription Drugs


